Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Drug Discovery Today|November 10, 2009
Epigenetic opportunities and challenges in cancerJonathan D Best, Nessa CareyDrug Discovery Today|October 27, 2010
Epigenetic therapies for non-oncology indicationsJonathan D Best, Nessa CareyCurrent Opinion in Pharmacology|June 20, 2006
Histone deacetylase inhibitors: gathering paceNessa Carey, Nicholas B La ThangueDrug Discovery Today|May 24, 2011
DNA demethylases: a new epigenetic frontier in drug discoveryNessa Carey, C Joana Marques, Wolf ReikAmerican Journal of Physiology. Heart and Circulatory Physiology|February 14, 2004
Flow-dependent increase of ICAM-1 on saphenous vein endothelium is sensitive to apaminSabena Sultan, Martin Gosling, Shadi Abu-Hayyeh, et al.Atherosclerosis|January 5, 2002
Generation and characterisation of human saphenous vein endothelial cell linesAriane Scoumanne, Tahereh Kalamati, Jill Moss, et al.Molecular Cancer Therapeutics|January 14, 2009
Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targetsJames M Flanagan, Juan M Funes, Stephen Henderson, et al.Current Biology : CB|April 9, 2002
Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cellsGiles E Duffield, Jonathan D Best, Bernhard H Meurers, et al.Journal of Neuroscience Methods|July 25, 2006
A comparative assessment of gamma-secretase activity in transgenic and non-transgenic rodent brainJulian L Goggi, Huw D Lewis, Joanie Mok, et al.Pageof 2